310 related articles for article (PubMed ID: 36307871)
21. Phenotypic heterogeneity of disseminated tumour cells is preset by primary tumour hypoxic microenvironments.
Fluegen G; Avivar-Valderas A; Wang Y; Padgen MR; Williams JK; Nobre AR; Calvo V; Cheung JF; Bravo-Cordero JJ; Entenberg D; Castracane J; Verkhusha V; Keely PJ; Condeelis J; Aguirre-Ghiso JA
Nat Cell Biol; 2017 Feb; 19(2):120-132. PubMed ID: 28114271
[TBL] [Abstract][Full Text] [Related]
22. Thrombospondins in bone remodeling and metastatic bone disease.
Carminati L; Taraboletti G
Am J Physiol Cell Physiol; 2020 Dec; 319(6):C980-C990. PubMed ID: 32936697
[TBL] [Abstract][Full Text] [Related]
23. Circulating and disseminated tumor cells: harbingers or initiators of metastasis?
Dasgupta A; Lim AR; Ghajar CM
Mol Oncol; 2017 Jan; 11(1):40-61. PubMed ID: 28085223
[TBL] [Abstract][Full Text] [Related]
24. Hematopoietic niche and bone meet.
Frisch BJ; Porter RL; Calvi LM
Curr Opin Support Palliat Care; 2008 Sep; 2(3):211-7. PubMed ID: 18685423
[TBL] [Abstract][Full Text] [Related]
25. Deficiency of chemokine receptor CCR1 causes osteopenia due to impaired functions of osteoclasts and osteoblasts.
Hoshino A; Iimura T; Ueha S; Hanada S; Maruoka Y; Mayahara M; Suzuki K; Imai T; Ito M; Manome Y; Yasuhara M; Kirino T; Yamaguchi A; Matsushima K; Yamamoto K
J Biol Chem; 2010 Sep; 285(37):28826-37. PubMed ID: 20571024
[TBL] [Abstract][Full Text] [Related]
26. The urokinase receptor (u-PAR)--a link between tumor cell dormancy and minimal residual disease in bone marrow?
Allgayer H; Aguirre-Ghiso JA
APMIS; 2008; 116(7-8):602-14. PubMed ID: 18834405
[TBL] [Abstract][Full Text] [Related]
27. Sustained Notch2 signaling in osteoblasts, but not in osteoclasts, is linked to osteopenia in a mouse model of Hajdu-Cheney syndrome.
Zanotti S; Yu J; Sanjay A; Schilling L; Schoenherr C; Economides AN; Canalis E
J Biol Chem; 2017 Jul; 292(29):12232-12244. PubMed ID: 28592489
[TBL] [Abstract][Full Text] [Related]
28. Tumor-supportive and osteoclastogenic changes induced by breast cancer-derived factors are reversed by inhibition of {gamma}-secretase.
Fong JE; Le Nihouannen D; Komarova SV
J Biol Chem; 2010 Oct; 285(41):31427-34. PubMed ID: 20679341
[TBL] [Abstract][Full Text] [Related]
29. Bone marrow NG2
Nobre AR; Risson E; Singh DK; Di Martino JS; Cheung JF; Wang J; Johnson J; Russnes HG; Bravo-Cordero JJ; Birbrair A; Naume B; Azhar M; Frenette PS; Aguirre-Ghiso JA
Nat Cancer; 2021 Mar; 2(3):327-339. PubMed ID: 34993493
[TBL] [Abstract][Full Text] [Related]
30. The presence of disseminated tumour cells in the bone marrow is inversely related to circulating free DNA in plasma in breast cancer dormancy.
Payne RE; Hava NL; Page K; Blighe K; Ward B; Slade M; Brown J; Guttery DS; Zaidi SA; Stebbing J; Jacob J; Yagüe E; Shaw JA; Coombes RC
Br J Cancer; 2012 Jan; 106(2):375-82. PubMed ID: 22166803
[TBL] [Abstract][Full Text] [Related]
31. Extracellular matrix: a gatekeeper in the transition from dormancy to metastatic growth.
Barkan D; Green JE; Chambers AF
Eur J Cancer; 2010 May; 46(7):1181-8. PubMed ID: 20304630
[TBL] [Abstract][Full Text] [Related]
32. Adhesion to osteopontin in the bone marrow niche regulates lymphoblastic leukemia cell dormancy.
Boyerinas B; Zafrir M; Yesilkanal AE; Price TT; Hyjek EM; Sipkins DA
Blood; 2013 Jun; 121(24):4821-31. PubMed ID: 23589674
[TBL] [Abstract][Full Text] [Related]
33. Disseminated tumor cells in bone marrow and circulating tumor cells in blood of breast cancer patients: current state of detection and characterization.
Riethdorf S; Pantel K
Pathobiology; 2008; 75(2):140-8. PubMed ID: 18544969
[TBL] [Abstract][Full Text] [Related]
34. New therapeutic targets for cancer bone metastasis.
Krzeszinski JY; Wan Y
Trends Pharmacol Sci; 2015 Jun; 36(6):360-73. PubMed ID: 25962679
[TBL] [Abstract][Full Text] [Related]
35. Notch2 pathway mediates breast cancer cellular dormancy and mobilisation in bone and contributes to haematopoietic stem cell mimicry.
Capulli M; Hristova D; Valbret Z; Carys K; Arjan R; Maurizi A; Masedu F; Cappariello A; Rucci N; Teti A
Br J Cancer; 2019 Jul; 121(2):157-171. PubMed ID: 31239543
[TBL] [Abstract][Full Text] [Related]
36. Bone marrow niches in the regulation of bone metastasis.
Chen F; Han Y; Kang Y
Br J Cancer; 2021 Jun; 124(12):1912-1920. PubMed ID: 33758331
[TBL] [Abstract][Full Text] [Related]
37. Modifying the osteoblastic niche with zoledronic acid in vivo-potential implications for breast cancer bone metastasis.
Haider MT; Holen I; Dear TN; Hunter K; Brown HK
Bone; 2014 Sep; 66(100):240-50. PubMed ID: 24971713
[TBL] [Abstract][Full Text] [Related]
38. Dynamic bioinspired coculture model for probing ER
Pradhan L; Moore D; Ovadia EM; Swedzinski SL; Cossette T; Sikes RA; van Golen K; Kloxin AM
Sci Adv; 2023 Mar; 9(10):eade3186. PubMed ID: 36888709
[TBL] [Abstract][Full Text] [Related]
39. Coordination of Fusion and Trafficking of Pre-osteoclasts at the Marrow-Bone Interface.
Søe K; Andersen TL; Hinge M; Rolighed L; Marcussen N; Delaisse JM
Calcif Tissue Int; 2019 Oct; 105(4):430-445. PubMed ID: 31236622
[TBL] [Abstract][Full Text] [Related]
40. Location matters: osteoblast and osteoclast distribution is modified by the presence and proximity to breast cancer cells in vivo.
Brown HK; Ottewell PD; Evans CA; Holen I
Clin Exp Metastasis; 2012 Dec; 29(8):927-38. PubMed ID: 22562502
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
